Back

COST Stock

Live symbol workspace

COST market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $1020.05
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for COST...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$969.05
Resistance
$1071.05

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Technical Context

Current price
$1020.05
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for COST skewed neutral (83 of 162 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

37%
▼ 4.2 pts vs previous week
Avg confidence across 132 calls in the last 7 days

What sources say

Neutral 83 articles
US voters say Trump’s Iran war not worth the cost — FT poll
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?
How a Major Grocery Store Chain Can Dramatically Lower the Cost of Food
Bearish 40 articles
US Service Sector Expands at a Slower Pace, Hiring Picks Up
Which Energy ETF Stands Out, the Global X MLPX or the First Trust EMLP?
As ACA enrollment falls by millions, Trump administration and policy gurus disagree on why
Bullish 39 articles
REET vs. RWR: Which Real Estate ETF Is the Better Buy?
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
Trump Accounts Default to State Street SPDR Portfolio S&P 500 ETF, Here Are 3 Better ETF Options

Insider Trading

Insider Role Date Type Value
DENMAN KENNETH D Director Jun 23 '26 Sale 847345.0
DENMAN KENNETH D Director Jun 23 '26 Proposed Sale 847346.0
Callans Patrick J Former Officer Jun 12 '26 Proposed Sale 972848.0
Callans Patrick J Former Officer Jun 05 '26 Proposed Sale 995373.0
Frates Caton Executive Vice … Apr 01 '26 Sale 695100.0
Caton Frates Officer Apr 01 '26 Proposed Sale 689758.0
Adamo Claudine Executive Vice … Mar 09 '26 Sale 732205.0
Adamo Claudine Officer Mar 09 '26 Proposed Sale 732205.0
Jones Teresa A. Executive Vice … Jan 21 '26 Sale 838318.0
Jones Teresa A. Officer Jan 21 '26 Proposed Sale 838318.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

COST News Intelligence (503 articles)

AI-curated news influencing COST price, sentiment, and trend

Explore All COST News with AI Analysis
Economy
2 hours, 12 minutes ago

US Service Sector Expands at a Slower Pace, Hiring Picks Up

The US service sector expanded in June at a slightly slower pace, but firms boosted payrolls as cost pressures eased.

Impact on COST: May pressure downward momentum
Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)
View full analysis →
Economy
4 hours, 54 minutes ago

REET vs. RWR: Which Real Estate ETF Is the Better Buy?

REET offers global diversification at lower cost, while RWR delivers U.S. real estate exposure and stronger returns.

Impact on COST: Potentially positive price action expected
Financial market analysis indicating bullish sentiment based on current trends. Medium (60%)
View full analysis →
Economy
1 day, 2 hours ago

Which Energy ETF Stands Out, the Global X MLPX or the First Trust EMLP?

Compare cost, diversification, and risk profiles as these two funds take different approaches to North American energy infrastructure exposure.

Impact on COST: May pressure downward momentum
Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)
View full analysis →
Global Markets & Finance
1 day, 4 hours ago

US voters say Trump’s Iran war not worth the cost — FT poll

Survey shows conflict is dragging down president’s approval ratings ahead of November midterms

Impact on COST: Neutral market sentiment indicated
Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)
View full analysis →
Economy
2 days ago

State Street Health Care ETF Tops Invesco Pharma on Cost and Size

Compare sector breadth, yield, and recent performance as these two healthcare ETFs take different approaches to growth and income.

Impact on COST: Potentially positive price action expected
Financial market analysis indicating bullish sentiment based on current trends. Medium (60%)
View full analysis →
Economy
2 days, 2 hours ago

Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?

Broad healthcare diversification or concentrated biotech growth? Compare cost, risk, and portfolio composition to find your fit.

Impact on COST: Neutral market sentiment indicated
Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)
View full analysis →
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis